Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional

This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry.  It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These ap...

Full description

Saved in:
Bibliographic Details
Main Author: Huml, Raymond A. (Author,
Corporate Author: SpringerLink (Online service)
Format: Electronic eBook
Published: New York, NY : Springer New York : Imprint: Springer, 2012.
Edition:1st ed. 2012.
Series:SpringerBriefs in Pharmaceutical Science & Drug Development,
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!